Research reported in The July 2 edition of Molecular Pain found preliminary evidence that multi-coil rTMS may have advantages over current, single-coil rTMS technology in reducing both acute pain and pain from fibromyalgia. The new technology may be superior in preferentially targeting the dorsal anterior cingulate cortex, an area always activated with pain. Additional research is needed to refine settings and configuration, as well as to better understand the mechanism of action of the technique. Read the abstract, with link to the full report, here.
View related content here.
Posted on July 15, 2013